약물정보

Home > 약물정보 > 뉴스레터 > FDA 신약

최신약물정보

2012년 이전 내용은 pdf로 보실 수 있습니다. 2012년 이전 내용 보기

최신약물정보
약물명	발간월
Gomekli®, Romvimza®, Blujepa®, Vanrafia®	2025.05 / 174호
Crenessity®, Ensacove®, Tryngolza®, Grafapex®	2025.03 / 173호
Itovebi® (Inavolisib), Orlynvah® (Sulopenem etzadroxil/probenecid), Revuforj® (Revumenib), Attruby® (Acoramidis)	2025.01 / 172호
Voranigo® (Vorasidenib), Yorvipath® (Palopegteriparatide), Livdelzi® (Seladelpar), Miplyffa® (Arimoclomol)	2024.11 / 171호
Rytelo® (Imetelstat), Iqirvo® (Elafibranor), Sofdra® (Sofpironium), Leqselvi® (Deuruxolitinib)	2024.09 / 170호
Vafseo® (Vadadustat), Zevtera® (Ceftobiprole medocaril sodium), Ojemda® (Tovorafenib), Xolremdi® (Mavorixafor)	2024.07 / 169호
Exblifep® (Cefepime/Enmetazobactam), Rezdiffra® (Resmetirom), Tryvio® (Aprocitentan), Duvyzat® (Givinostat)	2024.05 / 168호
Fabhalta® (Iptacopan), Filsuvez® (Birch triterpenes), Wainua® (Eplontersen), Zelsuvmi® (Berdazimer)	2024.03 / 167호
Agamree® (Vamorolone), Fluzaqla® (Fruquintinib), Augtyro® (Repotrectinib), Truqap® (Capivasertib), Ogsiveo® (Nirogacestat)	2024.01 / 166호
Xdemvy®(Lotilaner), Izervay® (Avacincaptad pegol), Sohonos® (Palovarotene), Aphexdatm® (Motixafortide), Ojjaara® (Momelotinib)	2023.11 / 165호
Miebo®(Perfluorohexyloctane), Xacduro®(Sulbactam/Durlobactam), Inefa®(Sotagliflozin), Litfulo®(Ritlecitinib), Vanflyta®(Quizartinib)	2023.09 / 164호
Daybue® (Trofinetide), Joenja® (Leniolisib), Qalsody® (Tofersen), Veozah® (Fezolinetant)	2023.07 / 163호
Jesduvroq® (Daprodustat), Filspari® (Sparsentan), Skycalrys® (Omaveloxolone), Zavzpret® (Zavegepant)	2023.05 / 162호
Brenzavvy® (Bexagliflozin), Jaypirca® (Pirtobrutinib), Orserdu® (Elacestrant)	2023.03 / 161호
Rezlidhia® (Olutasidenib), Krazati® (Adagrasib), Sunlenca® (Lenacapavir)	2023.01 / 160호